Autor: "Grantham J" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Comparison of Patient-Reported vs Physician-Estimated Angina in Patients Undergoing Elective and Urgent Percutaneous Coronary Intervention.
Autorzy :: Saxon JT; St Luke's Mid America Heart Institute, Kansas City, Missouri.; University of Missouri-Kansas City, Kansas City, Missouri.
Chan PS; St Luke's Mid America Heart Institute, Kansas City, Missouri.; University of Missouri-Kansas City, Kansas City, Missouri.
Tran AT; St Luke's Mid America Heart Institute, Kansas City, Missouri.; University of Missouri-Kansas City, Kansas City, Missouri.
Angraal S; University of Missouri-Kansas City, Kansas City, Missouri.
Jones PG; St Luke's Mid America Heart Institute, Kansas City, Missouri.; University of Missouri-Kansas City, Kansas City, Missouri.
Grantham JA; St Luke's Mid America Heart Institute, Kansas City, Missouri.; University of Missouri-Kansas City, Kansas City, Missouri.
Spertus JA; St Luke's Mid America Heart Institute, Kansas City, Missouri.; University of Missouri-Kansas City, Kansas City, Missouri.; Pokaż więcej
Źródło :: JAMA network open [JAMA Netw Open] 2020 Jun 01; Vol. 3 (6), pp. e207406. Date of Electronic Publication: 2020 Jun 01.
Typ publikacji :: Journal Article
MeSH Terms :: Angina Pectoris*/epidemiology
Angina Pectoris*/etiology
Myocardial Ischemia*/complications
Myocardial Ischemia*/epidemiology
Myocardial Ischemia*/surgery
Elective Surgical Procedures/*statistics & numerical data
Percutaneous Coronary Intervention/*statistics & numerical data
Aged ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Impact of Subintimal or Plaque Modification on Repeat Chronic Total Occlusion Angioplasty Following an Unsuccessful Attempt.
Autorzy :: Hirai T
Grantham JA
Gosch KL
Patterson C
Kirtane AJ
Lombardi W
Nicholson WJ
Moses J
Karmpaliotis D
Salisbury AC; Pokaż więcej
Źródło :: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2020 Apr 27; Vol. 13 (8), pp. 1010-1012.
Typ publikacji :: Letter; Observational Study
MeSH Terms :: Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/instrumentation
Plaque, Atherosclerotic*
Coronary Occlusion/*therapy
Aged ; Chronic Disease ; Coronary Occlusion/diagnostic imaging ; Coronary Occlusion/physiopathology ; Female ; Humans ; Male ; Middle Aged ; Retreatment ; Risk Assessment ; Risk Factors ; Stents ; Time Factors ; Treatment Failure
: Raport

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Appropriate Use Criteria and Health Status Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN-CTO Registry.
Autorzy :: Saxon JT; Saint Luke's Mid America Heart Institute, Kansas City, MO (J.T.S., J.A.G., A.C.S., Y.T., D.J.C., J.A.S., D.M.S.).; University of Missouri-Kansas City (J.T.S., J.A.G., A.C.S., D.J.C., J.A.S., D.M.S.).
Grantham JA; Saint Luke's Mid America Heart Institute, Kansas City, MO (J.T.S., J.A.G., A.C.S., Y.T., D.J.C., J.A.S., D.M.S.).; University of Missouri-Kansas City (J.T.S., J.A.G., A.C.S., D.J.C., J.A.S., D.M.S.).
Salisbury AC; Saint Luke's Mid America Heart Institute, Kansas City, MO (J.T.S., J.A.G., A.C.S., Y.T., D.J.C., J.A.S., D.M.S.).; University of Missouri-Kansas City (J.T.S., J.A.G., A.C.S., D.J.C., J.A.S., D.M.S.).
Sapontis J; MonashHeart, Victoria, Australia (J.S.).
Lombardi WL; University of Washington Medical Center, Seattle (W.L.L.).
Karmpaliotis D; Columbia University Medical Center/New York-Presbyterian Hospital (D.K., J.M.).
Moses J; Columbia University Medical Center/New York-Presbyterian Hospital (D.K., J.M.).
Nicholson WJ; WellSpan York Hospital, PA (W.J.N.).
Tang Y; Saint Luke's Mid America Heart Institute, Kansas City, MO (J.T.S., J.A.G., A.C.S., Y.T., D.J.C., J.A.S., D.M.S.).
Cohen DJ; Saint Luke's Mid America Heart Institute, Kansas City, MO (J.T.S., J.A.G., A.C.S., Y.T., D.J.C., J.A.S., D.M.S.).; University of Missouri-Kansas City (J.T.S., J.A.G., A.C.S., D.J.C., J.A.S., D.M.S.).
Spertus JA; Saint Luke's Mid America Heart Institute, Kansas City, MO (J.T.S., J.A.G., A.C.S., Y.T., D.J.C., J.A.S., D.M.S.).; University of Missouri-Kansas City (J.T.S., J.A.G., A.C.S., D.J.C., J.A.S., D.M.S.).
Safley DM; Saint Luke's Mid America Heart Institute, Kansas City, MO (J.T.S., J.A.G., A.C.S., Y.T., D.J.C., J.A.S., D.M.S.).; University of Missouri-Kansas City (J.T.S., J.A.G., A.C.S., D.J.C., J.A.S., D.M.S.).; Pokaż więcej
Źródło :: Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2020 Feb; Vol. 13 (2), pp. e008448. Date of Electronic Publication: 2020 Feb 11.
Typ publikacji :: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Health Status*
Cardiologists/*standards
Coronary Occlusion/*therapy
Guideline Adherence/*standards
Outcome and Process Assessment, Health Care/*standards
Percutaneous Coronary Intervention/*standards
Practice Guidelines as Topic/*standards
Practice Patterns, Physicians'/*standards
Aged ; Chronic Disease ; Clinical Decision-Making ; Coronary Occlusion/diagnosis ; Coronary Occlusion/physiopathology ; Female ; Health Status Indicators ; Humans ; Male ; Middle Aged ; Percutaneous Coronary Intervention/adverse effects ; Registries ; Surveys and Questionnaires ; Time Factors ; Treatment Outcome ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: A Detailed Analysis of Perforations During Chronic Total Occlusion Angioplasty.
Autorzy :: Hirai T; Saint Luke's Mid America Heart Institute, Kansas City, Missouri; Department of Medicine, Division of Cardiology, University of Missouri Kansas City, Kansas City, Missouri.
Nicholson WJ; York Hospital, York, Pennsylvania.
Sapontis J; Monash Heart, Melbourne, Australia.
Salisbury AC; Saint Luke's Mid America Heart Institute, Kansas City, Missouri; Department of Medicine, Division of Cardiology, University of Missouri Kansas City, Kansas City, Missouri.
Marso SP; Research Medical Center, Kansas City, Missouri.
Lombardi W; University of Washington, Seattle, Washington.
Karmpaliotis D; Columbia University, New York Presbyterian Hospital, New York, New York.
Moses J; Columbia University, New York Presbyterian Hospital, New York, New York.
Pershad A; Banner University Medical Center, Phoenix, Arizona.
Wyman RM; Torrance Medical Center, Torrance, California.
Spaedy A; Boone County Hospital, Columbia, Missouri.
Cook S; Peacehealth Sacred Heart Medical Center, Springfield, Oregon.
Doshi P; Alexian Brothers Medical Center, Chicago, Illinois.
Federici R; Presbyterian Health System, Albuquerque, New Mexico.
Nugent K; Saint Luke's Mid America Heart Institute, Kansas City, Missouri.
Gosch KL; Saint Luke's Mid America Heart Institute, Kansas City, Missouri.
Spertus JA; Saint Luke's Mid America Heart Institute, Kansas City, Missouri; Department of Medicine, Division of Cardiology, University of Missouri Kansas City, Kansas City, Missouri.
Grantham JA; Saint Luke's Mid America Heart Institute, Kansas City, Missouri; Department of Medicine, Division of Cardiology, University of Missouri Kansas City, Kansas City, Missouri. Electronic address: .; Pokaż więcej
Corporate Authors :: OPEN-CTO Study Group
Źródło :: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2019 Oct 14; Vol. 12 (19), pp. 1902-1912. Date of Electronic Publication: 2019 Jun 26.
Typ publikacji :: Comparative Study; Journal Article; Multicenter Study
MeSH Terms :: Coronary Occlusion/*therapy
Coronary Vessels/*injuries
Heart Injuries/*epidemiology
Percutaneous Coronary Intervention/*adverse effects
Aged ; Aged, 80 and over ; Cardiac Tamponade/epidemiology ; Chronic Disease ; Coronary Occlusion/diagnostic imaging ; Coronary Occlusion/mortality ; Coronary Vessels/diagnostic imaging ; Female ; Heart Injuries/diagnostic imaging ; Heart Injuries/mortality ; Heart Injuries/therapy ; Hospital Mortality ; Humans ; Male ; Middle Aged ; Percutaneous Coronary Intervention/mortality ; Pericardial Effusion/epidemiology ; Prospective Studies ; Registries ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome ; United States/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Late-term safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization: Final 4-year results from the evaluation of the XIENCE coronary stent, Performance, and Technique in Chronic Total Occlusions (EXPERT CTO) multicenter trial.
Autorzy :: Kandzari DE; Piedmont Heart Institute, Atlanta, Georgia.
Karmpaliotis D; Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York.
Kini AS; Mount Sinai Medical Center, New York, New York.
Moses JW; Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York.
Tummala PE; The Heart Center of Northeast Georgia Medical Center, Gainesville, Georgia.
Grantham JA; St. Luke's Mid-America Heart Institute, Kansas City, Missouri.
Orr C; St. Vincent's Heart Center, Indianapolis, Indiana.
Lombardi W; PeaceHealth St. Joseph Medical Center, Cardiovascular Center, North Cascade Cardiology, Bellingham, WA.
Nicholson WJ; York Hospital, York, Pennsylvania.
Lembo NJ; Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York.
Popma JJ; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Wang J; Abbott Vascular, Inc., Santa Clara, California.
Zhao W; Abbott Vascular, Inc., Santa Clara, California.
McGreevy R; Piedmont Heart Institute, Atlanta, Georgia.; Pokaż więcej
Źródło :: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2019 Oct 01; Vol. 94 (4), pp. 509-515. Date of Electronic Publication: 2019 Aug 24.
Typ publikacji :: Clinical Trial; Journal Article; Multicenter Study
MeSH Terms :: Drug-Eluting Stents*
Cardiovascular Agents/*administration & dosage
Coronary Occlusion/*therapy
Everolimus/*administration & dosage
Percutaneous Coronary Intervention/*instrumentation
Aged ; Cardiovascular Agents/adverse effects ; Chronic Disease ; Coronary Occlusion/diagnostic imaging ; Coronary Occlusion/mortality ; Coronary Occlusion/physiopathology ; Coronary Thrombosis/etiology ; Coronary Thrombosis/mortality ; Everolimus/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Myocardial Infarction/etiology ; Myocardial Infarction/mortality ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/mortality ; Prospective Studies ; Prosthesis Design ; Risk Factors ; Time Factors ; Treatment Outcome ; United States ; Vascular Patency
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status.
Autorzy :: Qintar M; Saint Luke's Mid America Heart Institute, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO.
Hirai T; Loyola University, Chicago, IL.
Arnold SV; Saint Luke's Mid America Heart Institute, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO.
Sheehy J; Saint Luke's Mid America Heart Institute, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO.
Sapontis J; Monash Cardiovascular Research Centre, MonashHeart, Monash Health & Department of Medicine (SCS at Monash), Monash University, Melbourne, Australia.
Jones P; Saint Luke's Mid America Heart Institute, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO.
Tang Y; Saint Luke's Mid America Heart Institute, Kansas City, MO.
Lombardi W; University of Washington, Seattle, WA.
Karmpaliotis D; Columbia University, New York City, NY.
Moses J; Columbia University, New York City, NY.
Patterson C; Saint Luke's Mid America Heart Institute, Kansas City, MO.
Nicholson WJ; York Hospital, York, PA.
Cohen DJ; Saint Luke's Mid America Heart Institute, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO.
Spertus JA; Saint Luke's Mid America Heart Institute, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO.
Grantham JA; Saint Luke's Mid America Heart Institute, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO.
Salisbury AC; Saint Luke's Mid America Heart Institute, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO. Electronic address: .; Pokaż więcej
Źródło :: American heart journal [Am Heart J] 2019 Aug; Vol. 214, pp. 1-8. Date of Electronic Publication: 2019 Apr 26.
Typ publikacji :: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Health Status*
Percutaneous Coronary Intervention*
Angina Pectoris/*drug therapy
Cardiovascular Agents/*administration & dosage
Coronary Occlusion/*surgery
Aged ; Angina Pectoris/diagnosis ; Angina Pectoris/surgery ; Calcium Channel Blockers/administration & dosage ; Chi-Square Distribution ; Chronic Disease ; Coronary Occlusion/complications ; Dyspnea/diagnosis ; Dyspnea/therapy ; Female ; Health Surveys ; Humans ; Logistic Models ; Male ; Myocardial Ischemia/complications ; Nitro Compounds/administration & dosage ; Prospective Studies ; Quality of Life ; Ranolazine/administration & dosage ; Registries ; Time Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention.
Autorzy :: Brilakis ES; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, MN (E.S.B., M.N.B.).
Mashayekhi K; Department of Cardiology and Angiology II University Heart Center Freiburg Bad Krozingen, Germany (K.M., H.J.B.).
Tsuchikane E; Toyohashi Heart Center, Aichi, Japan (E.T.).
Abi Rafeh N; St. George Hospital University Medical Center, Beirut, Lebanon (N.A.R.).
Alaswad K; Henry Ford Hospital, Detroit, MI (K.A.).
Araya M; Clínica Alemana and Instituto Nacional del Tórax, Santiago, Chile (M.A.).
Avran A; Arnault Tzank Institut St. Laurent Du Var Nice, France (A.A.).
Azzalini L; Interventional Cardiology Division, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy (L.A., M.C.).
Babunashvili AM; Department of Cardiovascular Surgery, Center for Endosurgery and Lithotripsy, Moscow, Russian Federation (A.M.B.).
Bayani B; Cardiology Department, Mehr Hospital, Mashhad, Iran (B.B.).
Bhindi R; Department of Cardiology, Royal North Shore Hospital and Kolling Institute, University of Sydney, Australia (R.B.).
Boudou N; Rangueil University Hospital, Toulouse, France (N.B.).
Boukhris M; Cardiology department, Abderrahment Mami Hospital, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia (M.B.).
Božinović NŽ; Department of Interventional Cardiology Clinic for Cardiovascular Diseases University Clinical Center Nis, Serbia (N.Z.B.).
Bryniarski L; II Department of Cardiology and Cardiovascular Interventions Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland (L.B.).
Bufe A; Department of Cardiology, Heartcentre Niederrhein, Helios Clinic Krefeld, Krefeld, Germany, Institute for Heart and Circulation Research, University of Cologne, Germany, and University of Witten/Herdecke, Witten, Germany (A.B.).
Buller CE; St. Michael's Hospital, Toronto, ON, Canada (C.E.B.).
Burke MN; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, MN (E.S.B., M.N.B.).
Büttner HJ; Department of Cardiology and Angiology II University Heart Center Freiburg Bad Krozingen, Germany (K.M., H.J.B.).
Cardoso P; Cardiology Department, Santa Maria University Hospital (CHULN), Lisbon Academic Medical Centre (CAML) and Centro Cardiovascular da Universidade de Lisboa (CCUL), Portugal (P.C.).
Carlino M; Interventional Cardiology Division, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy (L.A., M.C.).
Christiansen EH; Department of Cardiology, Aarhus University Hospital, Denmark (E.H.C.).
Colombo A; San Raffaele Hospital and Columbus Hospital, Milan, Italy (A.C.).
Croce K; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (K.C.).
Damas de Los Santos F; Interventional Cardiology Department, Instituto Nacional de Cardiología Ignacio Chávez Mexico City, Mexico (F.D.d.l.S.).
De Martini T; SIU School of Medicine, Memorial Medical Center, Springfield, IL (T.D.M.).
Dens J; Department of Cardiology, Hospital Oost-Limburg, Genk, Belgium (J.D.).
Di Mario C; Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy (C.D.M.).
Dou K; Center for Coronary Heart Disease, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, and National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (K.D.).
Egred M; Freeman Hospital and Newcastle University, Newcastle upon Tyne, United Kingdom (M.E.).
ElGuindy AM; Department of Cardiology, Aswan Heart Center, Egypt (A.M.E.).; National Heart and Lung Institute, Imperial College London, United Kingdom (A.M.E.).
Escaned J; Hospital Clinico San Carlos IDISSC and Universidad Complutense de Madrid, Spain (J.E.).
Furkalo S; Department of Endovascular Surgery and Angiography, National Institute of Surgery and Transplantology of AMS of Ukraine, Kiev (S.F.).
Gagnor A; Department of Invasive Cardiology, Maria Vittoria Hospital, Turin, Italy (A.G.).
Galassi AR; Chair of Cardiology, Department of PROMISE, University of Palermo, Italy (A.R.G.).
Garbo R; Director of Interventional Cardiology, San Giovanni Bosco Hospital, Turin, Italy (R.G.).
Ge J; Zhongshan Hospital, Fudan University, Shanghai, China (J.G.).
Goel PK; Sanjay Gandhi Post Graduate Institute of Medical Sciences Lucknow, India (P.K.G.).
Goktekin O; Memorial Hospital, Istanbul, Turkey (O.G.).
Grancini L; Centro Cardiologico Monzino, IRCCS, Milan, Italy (L.G.).
Grantham JA; Saint Luke's Mid America Heart Institute, Kansas City, MO (J.A.G.).
Hanratty C; Belfast Health and Social Care Trust, United Kingdom (C.H., S.W.).
Harb S; LKH Graz II, Standort West, Kardiologie, Teaching Hospital of the University of Graz, Austria (S.H.).
Harding SA; Wellington Hospital, Capital and Coast District Health Board, New Zealand (S.A.H.).
Henriques JPS; Academic Medical Centre of the University of Amsterdam, The Netherlands (J.P.S.H.).
Hill JM; King's College Hospital, London, United Kingdom (J.M.H.).
Jaffer FA; Cardiology Division, Massachusetts General Hospital, Boston (F.A.J.).
Jang Y; Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea (Y.J.).
Jussila R; Helsinki Heart Hospital, Finland (R.J.).
Kalnins A; Department of Cardiology, Eastern Clinical University Hospital, Riga, Latvia (A. Kalnins).
Kalyanasundaram A; Promed Hospital, Chennai, India (A. Kalyanasundaram).
Kandzari DE; Piedmont Heart Institute, Atlanta, GA (D.E.K.).
Kao HL; Department of Internal Medicine, National Taiwan University Hospital, Taipei(H.-L.K.).
Karmpaliotis D; Columbia University, New York (D.K.).
Kassem HH; Cardiology Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Egypt(H.H.K.).; Fujairah Hospital, United Arab Emirates (H.H.K.).
Knaapen P; Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands (P.K.).
Kornowski R; Department of Cardiology, Rabin Medical Center, Petach Tikva, 'Sackler' School of Medicine, Tel Aviv University, Petach Tikva, Israel (R.K.).
Krestyaninov O; Meshalkin Novosibrisk Research Institute, Russia (O.K.).
Kumar AVG; Department of Cardiology, Dr LH Hiranandani Hospital, Mumbai, India (A.V.G.K.).
Laanmets P; North Estonia Medical Center Foundation, Tallinn, Estonia(P. Laanmets).
Lamelas P; Department of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular de Buenos Aires, Argentina (P. Lamelas).; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada (P. Lamelas).
Lee SW; Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.-W.L.).
Lefevre T; Institut Cardiovasculaire Paris Sud Hopital prive Jacques Cartier, Massy, France (T.L.).
Li Y; Department of Cardiology, the First Affiliated Hospital of Harbin Medical University, China (Y.L.).
Lim ST; Department of Cardiology, National Heart Centre Singapore (S.-T.L.).
Lo S; Department of Cardiology, Liverpool Hospital and The University of New South Wales, Sydney, Australia (S.L.).
Lombardi W; University of Washington, Seattle (W.L.).
McEntegart M; Golden Jubilee National Hospital, Glasgow, United Kingdom (M. McEntegart).
Munawar M; Binawaluya Cardiac Center, Jakarta, Indonesia (M. Munawar).
Navarro Lecaro JA; Médico Cardiólogo Universitario - Hemodinamista en Hospital de Especialidades Eugenio Espejo y Hospital de los Valles, Ecuador (J.A.N.L.).
Ngo HM; Choray Hospital, Vietnam (H.M.N.).
Nicholson W; WellSpan Health System, York, PA (W.N.).
Olivecrona GK; Skane University Hospital, University of Lund, Sweden (G.K.O.).
Padilla L; Department of Interventional Cardiology and Endovascular Therapeutics, ICBA, Instituto Cardiovascular, Buenos Aires, Argentina (L.P.).
Postu M; Cardiology Department, University of Medicine and Pharmacy 'Carol Davila,' Institute of Cardiovascular Diseases 'Prof. Dr. C.C. Iliescu,' Bucharest, Romania (M.P.).
Quadros A; Instituto de Cardiologia / Fundação Universitária de Cardiologia - IC/FUC, Porto Alegre, RS - Brazil (A.Q.).
Quesada FH; Interventional Cardiology Department, Clinica Comfamiliar Pereira City, Colombia (F.H.Q.).
Prakasa Rao VS; Hyderguda Apollo, Hyderabad, India (V.S.P.R.).
Reifart N; Department of Cardiology, Main Taunus Heart Institute, Bad Soden, Germany (N.R.).
Saghatelyan M; Nork-Marash Medical Center, Yerevan, Armenia (M.S.).
Santiago R; Hospital Pavia Santurce, PCI Cardiology Group, San Juan, Puerto Rico (R.S.T.).
Sianos G; AHEPA University Hospital, Thessaloniki, Greece (G.S.).
Smith E; Department of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom (E.S.).
C Spratt J; St George's University Hospital NHS Trust, London, United Kingdom (J.S.).
Stone GW; Center for Interventional Vascular Therapy, Division of Cardiology, New York-Presbyterian Hospital/Columbia University Medical Center (G.W.S.).
Strange JW; Department of Cardiology, Bristol Royal Infirmary, United Kingdom (J.W.S.).
Tammam K; Cardiac Center of Excellence, International Medical Center, Jeddah, Saudi Arabia (K.T.).
Ungi I; 2nd Department of Internal Medicine and Cardiology Center, University of Szeged, Hungary (I.U.).
Vo M; Mazankowski Alberta Heart Institute, Edmonton, AB, Canada (M.V.).
Vu VH; Interventional Cardiology Department, Heart Center, University Medical Center at Ho Chi Minh City, and University of Medicine and Pharmacy, Vietnam (H.V.).
Walsh S; Belfast Health and Social Care Trust, United Kingdom (C.H., S.W.).
Werner GS; Medizinische Klinik I Klinikum Darmstadt GmbH, Germany (G.W.).
Wollmuth JR; Providence Heart and Vascular Institute, Portland, OR (J.R.W.).
Wu EB; Prince of Wales Hospital, Hong Kong (E.W.).
Wyman RM; Torrance Memorial Medical Center, CA (R.M.W.).
Xu B; Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing (B.X.).
Yamane M; Saitima St. Luke's International Hospital, Tokyo, Japan (M.Y.).
Ybarra LF; London Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada (L.F.Y.).
Yeh RW; Beth Israel Deaconess Medical Center, Boston, MA (R.W.Y.).
Zhang Q; Shanghai East Hospital, Tongji University, China (Q.Z.).
Rinfret S; McGill University Health Centre, McGill University, Montreal, QC, Canada (S.R.).; Pokaż więcej
Źródło :: Circulation [Circulation] 2019 Jul 30; Vol. 140 (5), pp. 420-433. Date of Electronic Publication: 2019 Jul 29.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Coronary Occlusion/*diagnostic imaging
Coronary Occlusion/*surgery
Percutaneous Coronary Intervention/*standards
Practice Guidelines as Topic/*standards
Chronic Disease ; Collateral Circulation/physiology ; Coronary Angiography/methods ; Coronary Angiography/standards ; Coronary Vessels/diagnostic imaging ; Coronary Vessels/surgery ; Humans ; Percutaneous Coronary Intervention/methods ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention.
Autorzy :: Hirai T; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., M.Q., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).; University of Missouri Kansas City (T.H., M.Q., J.A.G., D.J.C., J.A.S., A.C.S.).
Qintar M; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., M.Q., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).; University of Missouri Kansas City (T.H., M.Q., J.A.G., D.J.C., J.A.S., A.C.S.).
Grantham JA; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., M.Q., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).; University of Missouri Kansas City (T.H., M.Q., J.A.G., D.J.C., J.A.S., A.C.S.).
Sapontis J; Monash Heart, Melbourne, VIC, Australia (J.S.).
Cohen DJ; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., M.Q., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).; University of Missouri Kansas City (T.H., M.Q., J.A.G., D.J.C., J.A.S., A.C.S.).
Lombardi W; University of Washington, Seattle (W.L.).
Karmpaliotis D; Columbia University, New York Presbyterian Hospital (D.K., J.M.).
Moses J; Columbia University, New York Presbyterian Hospital (D.K., J.M.).
Nicholson WJ; WellSpan York Hospital, York, PA (W.J.N.).
Nugent K; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., M.Q., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).
Gosch KL; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., M.Q., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).
Spertus JA; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., M.Q., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).; University of Missouri Kansas City (T.H., M.Q., J.A.G., D.J.C., J.A.S., A.C.S.).
Salisbury AC; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., M.Q., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).; University of Missouri Kansas City (T.H., M.Q., J.A.G., D.J.C., J.A.S., A.C.S.).; Pokaż więcej
Źródło :: Circulation. Cardiovascular quality and outcomes [Circ Cardiovasc Qual Outcomes] 2019 Jun; Vol. 12 (6), pp. e005287. Date of Electronic Publication: 2019 Jun 12.
Typ publikacji :: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Percutaneous Coronary Intervention*/adverse effects
Angina Pectoris/*therapy
Cardiovascular Agents/*administration & dosage
Coronary Occlusion/*therapy
Aged ; Angina Pectoris/diagnostic imaging ; Angina Pectoris/physiopathology ; Cardiovascular Agents/adverse effects ; Chronic Disease ; Coronary Occlusion/diagnostic imaging ; Coronary Occlusion/physiopathology ; Drug Administration Schedule ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Registries ; Time Factors ; Treatment Outcome ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Depression and Angina Among Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention: The OPEN-CTO Registry.
Autorzy :: Yeh RW; Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. Electronic address: .
Tamez H; Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Secemsky EA; Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Grantham JA; Saint Luke's Mid America Heart Institute/UMKC, Kansas City, Missouri.
Sapontis J; MonashHeart, Melbourne, Victoria, Australia.
Spertus JA; Saint Luke's Mid America Heart Institute/UMKC, Kansas City, Missouri.
Cohen DJ; Saint Luke's Mid America Heart Institute/UMKC, Kansas City, Missouri.
Nicholson WJ; York Hospital, York, Pennsylvania.
Gosch K; Saint Luke's Mid America Heart Institute/UMKC, Kansas City, Missouri.
Jones PG; Saint Luke's Mid America Heart Institute/UMKC, Kansas City, Missouri.
Valsdottir LR; Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Bruckel J; Division of Cardiology, University of Rochester, Rochester, New York.
Lombardi WL; Division of Cardiology, University of Washington, Seattle, Washington.
Jaffer FA; Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts.; Pokaż więcej
Źródło :: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2019 Apr 08; Vol. 12 (7), pp. 651-658. Date of Electronic Publication: 2019 Mar 13.
Typ publikacji :: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Affect*/drug effects
Percutaneous Coronary Intervention*
Angina Pectoris/*therapy
Coronary Occlusion/*therapy
Depression/*psychology
Aged ; Angina Pectoris/diagnostic imaging ; Angina Pectoris/epidemiology ; Antidepressive Agents/therapeutic use ; Chronic Disease ; Coronary Occlusion/diagnostic imaging ; Coronary Occlusion/epidemiology ; Depression/diagnosis ; Depression/drug therapy ; Depression/epidemiology ; Female ; Health Status ; Humans ; Male ; Mental Health ; Middle Aged ; Prevalence ; Registries ; Time Factors ; Treatment Outcome ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Physical Activity After Percutaneous Coronary Intervention for Chronic Total Occlusion and Its Association With Health Status.
Autorzy :: Peri-Okonny PA; 1 Saint Luke's Mid America Heart Institute Kansas City MO.
Spertus JA; 1 Saint Luke's Mid America Heart Institute Kansas City MO.; 2 University of Missouri-Kansas City Kansas City MO.
Grantham JA; 1 Saint Luke's Mid America Heart Institute Kansas City MO.; 2 University of Missouri-Kansas City Kansas City MO.
Gosch K; 1 Saint Luke's Mid America Heart Institute Kansas City MO.
Kirtane A; 3 Columbia University New York City NY.
Sapontis J; 4 Monash Heart Hospital Melbourne Victoria Australia.
Lombardi W; 5 University of Washington Seattle WA.
Karmpaliotis D; 3 Columbia University New York City NY.
Moses J; 3 Columbia University New York City NY.
Nicholson W; 6 Wellspan York Hospital York PA.
Salisbury AC; 1 Saint Luke's Mid America Heart Institute Kansas City MO.; 2 University of Missouri-Kansas City Kansas City MO.; Pokaż więcej
Źródło :: Journal of the American Heart Association [J Am Heart Assoc] 2019 Apr 02; Vol. 8 (7), pp. e011629.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Exercise*
Health Status*
Percutaneous Coronary Intervention*
Coronary Occlusion/*surgery
Aged ; Angina Pectoris/drug therapy ; Angina Pectoris/etiology ; Angina Pectoris/physiopathology ; Cardiovascular Agents/therapeutic use ; Chronic Disease ; Coronary Occlusion/complications ; Coronary Occlusion/physiopathology ; Exercise Tolerance ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Nitrates/therapeutic use ; Ranolazine/therapeutic use ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Quality of Life Changes After Chronic Total Occlusion Angioplasty in Patients With Baseline Refractory Angina.
Autorzy :: Hirai T; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).; University of Missouri Kansas City (T.H., J.A.G., D.J.C., J.A.S., A.C.S.).
Grantham JA; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).; University of Missouri Kansas City (T.H., J.A.G., D.J.C., J.A.S., A.C.S.).
Sapontis J; Monash Heart, Melbourne, Australia (J.S.).
Cohen DJ; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).; University of Missouri Kansas City (T.H., J.A.G., D.J.C., J.A.S., A.C.S.).
Marso SP; Research Medical Center, Kansas City, MO (S.P.M.).
Lombardi W; University of Washington, Seattle (W.L.).
Karmpaliotis D; Columbia University, New York Presbyterian Hospital (D.K., J.M.).
Moses J; Columbia University, New York Presbyterian Hospital (D.K., J.M.).
Nicholson WJ; York Hospital, PA (W.J.N.).
Pershad A; Banner Good Samaritan Medical Center, Phoenix, AZ (A.P.).; Banner Heart, Mesa, AZ (A.P.).
Wyman RM; Torrance Medical Center, CA (R.M.W.).
Spaedy A; Boone County Hospital, Columbia, MO (A.S.).
Cook S; Peacehealth Sacred Heart Medical Center, Springfield, OR (S.C.).
Doshi P; Alexian Brothers Medical Center, Chicago, IL (P.D.).
Federici R; FHS, Albuquerque, NM (R.F.).
Nugent K; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).
Gosch KL; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).
Spertus JA; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).; University of Missouri Kansas City (T.H., J.A.G., D.J.C., J.A.S., A.C.S.).
Salisbury AC; Saint Luke's Mid America Heart Institute, Kansas City, MO (T.H., J.A.G., D.J.C., K.N., K.L.G., J.A.S., A.C.S.).; University of Missouri Kansas City (T.H., J.A.G., D.J.C., J.A.S., A.C.S.).; Pokaż więcej
Źródło :: Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2019 Mar; Vol. 12 (3), pp. e007558.
Typ publikacji :: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Percutaneous Coronary Intervention*/adverse effects
Quality of Life*
Angina Pectoris/*therapy
Coronary Occlusion/*therapy
Aged ; Angina Pectoris/diagnosis ; Angina Pectoris/epidemiology ; Angina Pectoris/psychology ; Cardiovascular Agents/therapeutic use ; Chronic Disease ; Coronary Occlusion/diagnosis ; Coronary Occlusion/epidemiology ; Coronary Occlusion/psychology ; Drug Resistance ; Female ; Health Status ; Humans ; Male ; Middle Aged ; Prospective Studies ; Registries ; Risk Factors ; Time Factors ; Treatment Outcome ; United States/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty: Insights From the OPEN-CTO Registry.
Autorzy :: Salisbury AC; Saint Luke's Mid America Heart Institute, Kansas City, Missouri; University of Missouri-Kansas City, Kansas City, Missouri. Electronic address: .
Karmpaliotis D; Columbia University Medical Center and New York Presbyterian Hospital, New York, New York.
Grantham JA; Saint Luke's Mid America Heart Institute, Kansas City, Missouri; University of Missouri-Kansas City, Kansas City, Missouri.
Sapontis J; Monash Heart, Melbourne, Australia.
Meng Q; Saint Luke's Mid America Heart Institute, Kansas City, Missouri.
Magnuson EA; Saint Luke's Mid America Heart Institute, Kansas City, Missouri; University of Missouri-Kansas City, Kansas City, Missouri.
Gada H; PinnacleHealth Cardiovascular Institute, Wormleysburg, Pennsylvania.
Lombardi W; University of Washington School of Medicine, Seattle, Washington.
Moses J; Columbia University Medical Center and New York Presbyterian Hospital, New York, New York.
Li H; Saint Luke's Mid America Heart Institute, Kansas City, Missouri.
Arnold SV; Saint Luke's Mid America Heart Institute, Kansas City, Missouri; University of Missouri-Kansas City, Kansas City, Missouri.
Baron SJ; Saint Luke's Mid America Heart Institute, Kansas City, Missouri; University of Missouri-Kansas City, Kansas City, Missouri.
Spertus JA; Saint Luke's Mid America Heart Institute, Kansas City, Missouri; University of Missouri-Kansas City, Kansas City, Missouri.
Cohen DJ; Saint Luke's Mid America Heart Institute, Kansas City, Missouri; University of Missouri-Kansas City, Kansas City, Missouri.; Pokaż więcej
Źródło :: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2019 Feb 25; Vol. 12 (4), pp. 323-331. Date of Electronic Publication: 2019 Jan 30.
Typ publikacji :: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Hospital Costs*
Coronary Occlusion/*economics
Coronary Occlusion/*therapy
Length of Stay/*economics
Percutaneous Coronary Intervention/*adverse effects
Percutaneous Coronary Intervention/*economics
Aged ; Chronic Disease ; Coronary Occlusion/diagnostic imaging ; Female ; Heart Injuries/economics ; Heart Injuries/etiology ; Heart Injuries/therapy ; Humans ; Male ; Middle Aged ; Models, Economic ; Myocardial Infarction/economics ; Myocardial Infarction/etiology ; Myocardial Infarction/therapy ; Prospective Studies ; Registries ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Algorithmic solutions to common problems encountered during chronic total occlusion angioplasty: The algorithms within the algorithm.
Autorzy :: Riley RF; Christ Hospital Heart and Vascular Center and Lindner Center for Research and Education, Cincinnati, Ohio.
Walsh SJ; Belfast Health and Social Care Trust, Belfast, UK.
Kirtane AJ; Columbia University, New York, New York.
Michael Wyman R; Torrance Memorial Medical Center, Torrance, California.
Nicholson WJ; WellSpan York Hospital, York, Pennsylvania.
Azzalini L; San Raffaele Scientific Institute, Milan, Italy.
Spratt JC; St George's University Hospital NHS Trust, London, UK.
Kalra S; Einstein Healthcare Network, Philadelphia, Pennsylvania.
Hanratty CG; Belfast Health and Social Care Trust, Belfast, UK.
Pershad A; Banner University Medical Center, Phoenix, Arizona.
DeMartini T; Edward-Elmhurst Health, Naperville, Illinois.
Karmpaliotis D; Columbia University, New York, New York.
Lombardi WL; University of Washington, Seattle, Washington.
Aaron Grantham J; St. Luke's Mid America Heart Institute, Kansas City, Missouri.; Pokaż więcej
Źródło :: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2019 Feb 01; Vol. 93 (2), pp. 286-297. Date of Electronic Publication: 2018 Nov 23.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Algorithms*
Critical Pathways*
Coronary Occlusion/*therapy
Percutaneous Coronary Intervention/*adverse effects
Chronic Disease ; Clinical Decision-Making ; Consensus ; Coronary Angiography ; Coronary Occlusion/diagnostic imaging ; Humans ; Percutaneous Coronary Intervention/instrumentation ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Prevalence, predictors, and health status implications of periprocedural complications during coronary chronic total occlusion angioplasty.
Autorzy :: Riley RF; The Christ Hospital Heart and Vascular Center and The Lindner Research Center, Cincinnati, OH, USA.
Sapontis J
Kirtane AJ
Karmpaliotis D
Kalra S
Jones PG
Lombardi WL
Grantham JA
McCabe JM; Pokaż więcej
Źródło :: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2018 Dec 07; Vol. 14 (11), pp. e1199-e1206. Date of Electronic Publication: 2018 Dec 07.
Typ publikacji :: Journal Article
MeSH Terms :: Coronary Occlusion*/epidemiology
Percutaneous Coronary Intervention*
Chronic Disease ; Coronary Angiography ; Health Status ; Humans ; Prevalence ; Registries ; Risk Factors ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Safety and efficacy of dedicated guidewire and microcatheter technology for chronic total coronary occlusion revascularization: principal results of the Asahi Intecc Chronic Total Occlusion Study.
Autorzy :: Kandzari DE; Piedmont Heart Institute, Atlanta, Georgia.
Grantham JA; St Luke's Mid-America Heart Institute and the University of Missouri Kansas City, Kansas City, Missouri.
Karmpaliotis D; Division of Cardiology, Columbia University Medical Center, New York, New York.
Lombardi W; Division of Cardiology, University of Washington, Seattle, Washington.
Moses JW; Division of Cardiology, Columbia University Medical Center, New York, New York.
Nicholson W; WellSpan Cardiology, York, Pennsylvania.
Cook S; Oregon Heart and Vascular Institute, Springfield, Oregon.
Pershad A; Banner Health-University Medical Center, Phoenix, Arizona.
Popma JJ; Department of Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Pokaż więcej
Źródło :: Coronary artery disease [Coron Artery Dis] 2018 Dec; Vol. 29 (8), pp. 618-623.
Typ publikacji :: Clinical Trial; Journal Article; Multicenter Study
MeSH Terms :: Cardiac Catheters*
Cardiac Catheterization/*instrumentation
Coronary Occlusion/*therapy
Percutaneous Coronary Intervention/*instrumentation
Aged ; Cardiac Catheterization/adverse effects ; Cardiac Catheterization/mortality ; Chronic Disease ; Coronary Angiography ; Coronary Occlusion/diagnostic imaging ; Coronary Occlusion/mortality ; Coronary Occlusion/physiopathology ; Equipment Design ; Female ; Hospital Mortality ; Humans ; Male ; Middle Aged ; Miniaturization ; Myocardial Infarction/etiology ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/mortality ; Prospective Studies ; Risk Factors ; Time Factors ; Treatment Outcome ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Impella-assisted chronic total occlusion percutaneous coronary interventions: A multicenter retrospective analysis.
Autorzy :: Riley RF; The Christ Hospital Heart and Vascular Center and The Lindner Research Center, Cincinnati, Ohio.
McCabe JM; University of Washington, Washington.
Kalra S; Albert Einstein College of Medicine, New York.
Lazkani M; Banner University Medical Center Clinic, Arizon.
Pershad A; Banner University Medical Center Clinic, Arizon.
Doshi D; Columbia University, New York.
Kirtane AJ; Columbia University, New York.
Nicholson W; Wellspan Health, Pennsylvania.
Kearney K; University of Washington, Washington.
Demartini T; Advocate Heart Institute, Illinois.
Aaron Grantham J; University of Missouri, Kansas City, Missouri.; Mid America Heart Institute, Kansas City, Missouri.
Moses J; Columbia University, New York.
Lombardi W; University of Washington, Washington.
Karmpaliotis D; Columbia University, New York.; Pokaż więcej
Źródło :: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2018 Dec 01; Vol. 92 (7), pp. 1261-1267. Date of Electronic Publication: 2018 Jul 18.
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: Heart-Assist Devices*
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/mortality
Coronary Occlusion/*therapy
Prosthesis Implantation/*instrumentation
Ventricular Dysfunction, Left/*therapy
Aged ; Chronic Disease ; Coronary Occlusion/diagnostic imaging ; Coronary Occlusion/mortality ; Coronary Occlusion/physiopathology ; Female ; Hemodynamics ; Humans ; Male ; Middle Aged ; Prosthesis Design ; Prosthesis Implantation/adverse effects ; Prosthesis Implantation/mortality ; Retrospective Studies ; Risk Factors ; Time Factors ; Treatment Outcome ; United States ; Ventricular Dysfunction, Left/diagnostic imaging ; Ventricular Dysfunction, Left/mortality ; Ventricular Dysfunction, Left/physiopathology ; Ventricular Function, Left
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights From the OPEN-CTO Registry.
Autorzy :: Khariton Y; Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, Missouri.
Airhart S; University of Arizona Medical Center, Tucson, Arizona.
Salisbury AC; Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, Missouri.
Spertus JA; Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, Missouri.
Gosch KL; Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, Missouri.
Grantham JA; Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, Missouri.
Karmpaliotis D; Columbia University Medical Center, New York Presbyterian Hospital, New York, New York.
Moses JW; Columbia University Medical Center, New York Presbyterian Hospital, New York, New York.
Nicholson WJ; York Hospital, York, Pennsylvania.
Cohen DJ; Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, Missouri.
Lombardi W; University of Washington, Seattle, Washington.
Sapontis J; The Avenue Hospital and Monash Medical Center, Windsor, Victoria, Australia.
McCabe JM; University of Washington, Seattle, Washington. Electronic address: .; Pokaż więcej
Źródło :: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2018 Nov 26; Vol. 11 (22), pp. 2276-2283.
Typ publikacji :: Comparative Study; Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Health Status*
Percutaneous Coronary Intervention*/adverse effects
Stroke Volume*
Ventricular Function, Left*
Cardiomyopathies/*physiopathology
Coronary Occlusion/*therapy
Ventricular Dysfunction, Left/*physiopathology
Aged ; Cardiomyopathies/diagnostic imaging ; Chronic Disease ; Coronary Occlusion/diagnostic imaging ; Coronary Occlusion/physiopathology ; Female ; Humans ; Male ; Middle Aged ; Recovery of Function ; Registries ; Risk Factors ; Severity of Illness Index ; Time Factors ; Treatment Outcome ; United States ; Ventricular Dysfunction, Left/diagnostic imaging
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Randomized Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusions: The CrossBoss First Trial.
Autorzy :: Karacsonyi J; Department of Cardiovascular Diseases, VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, Texas; Department of Cardiovascular Diseases, Division of Invasive Cardiology, Second Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
Tajti P; Department of Cardiovascular Diseases, Division of Invasive Cardiology, Second Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary; Department of Cardiovascular Diseases, Minneapolis Heart Institute, Minneapolis, Minnesota.
Rangan BV; Department of Cardiovascular Diseases, VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, Texas.
Halligan SC; Department of Cardiovascular Diseases, North Central Heart/Avera Heart Hospital, Sioux Falls, South Dakota.
Allen RH; Department of Cardiovascular Diseases, North Central Heart/Avera Heart Hospital, Sioux Falls, South Dakota.
Nicholson WJ; Department of Cardiovascular Diseases, York Hospital-Wellspan Health System, York, Pennsylvania.
Harvey JE; Department of Cardiovascular Diseases, York Hospital-Wellspan Health System, York, Pennsylvania.
Spaedy AJ; Department of Cardiovascular Diseases, Missouri Heart Center, Columbia, Missouri.
Jaffer FA; Department of Cardiovascular Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Grantham JA; Department of Cardiovascular Diseases, St. Luke's Mid America Heart Institute, Kansas, Missouri.
Salisbury A; Department of Cardiovascular Diseases, St. Luke's Mid America Heart Institute, Kansas, Missouri.
Hart AJ; Department of Cardiovascular Diseases, St. Luke's Mid America Heart Institute, Kansas, Missouri.
Safley DM; Department of Cardiovascular Diseases, St. Luke's Mid America Heart Institute, Kansas, Missouri.
Lombardi WL; Department of Cardiovascular Diseases, University of Washington, Seattle, Washington.
Hira R; Department of Cardiovascular Diseases, University of Washington, Seattle, Washington.
Don C; Department of Cardiovascular Diseases, University of Washington, Seattle, Washington.
McCabe JM; Department of Cardiovascular Diseases, University of Washington, Seattle, Washington.
Burke MN; Department of Cardiovascular Diseases, Minneapolis Heart Institute, Minneapolis, Minnesota.
Alaswad K; Department of Cardiovascular Diseases, Henry Ford Hospital, Detroit, Michigan.
Koenig GC; Department of Cardiovascular Diseases, Henry Ford Hospital, Detroit, Michigan.
Sanghvi KA; Department of Cardiovascular Diseases, Deborah Heart and Lung Center, Browns Mills, New Jersey.
Ice D; Department of Cardiovascular Diseases, Deborah Heart and Lung Center, Browns Mills, New Jersey.
Kovach RC; Department of Cardiovascular Diseases, Deborah Heart and Lung Center, Browns Mills, New Jersey.
Varghese V; Department of Cardiovascular Diseases, Deborah Heart and Lung Center, Browns Mills, New Jersey.
Murad B; Department of Cardiovascular Diseases, United Heart and Vascular Clinic, Saint Paul, Minnesota.
Baran KW; Department of Cardiovascular Diseases, United Heart and Vascular Clinic, Saint Paul, Minnesota.
Resendes E; Department of Cardiovascular Diseases, VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, Texas.
Martinez-Parachini JR; Department of Cardiovascular Diseases, VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, Texas; Department of Cardiovascular Diseases, Oklahoma University Medical Center, Oklahoma City, Oklahoma.
Karatasakis A; Department of Cardiovascular Diseases, VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, Texas.
Danek BA; Department of Cardiovascular Diseases, VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, Texas.
Iwnetu R; Department of Cardiovascular Diseases, VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, Texas.
Roesle M; Department of Cardiovascular Diseases, VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, Texas.
Khalili H; Department of Cardiovascular Diseases, VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, Texas.
Banerjee S; Department of Cardiovascular Diseases, VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, Texas.
Brilakis ES; Department of Cardiovascular Diseases, VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, Texas; Department of Cardiovascular Diseases, Minneapolis Heart Institute, Minneapolis, Minnesota. Electronic address: .; Pokaż więcej
Źródło :: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2018 Feb 12; Vol. 11 (3), pp. 225-233.
Typ publikacji :: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :: Cardiac Catheterization/*methods
Coronary Occlusion/*surgery
Percutaneous Coronary Intervention/*methods
Aged ; Cardiac Catheterization/adverse effects ; Cardiac Catheterization/economics ; Cardiac Catheterization/instrumentation ; Cardiac Catheters ; Chronic Disease ; Coronary Angiography ; Coronary Occlusion/diagnostic imaging ; Coronary Occlusion/economics ; Coronary Occlusion/physiopathology ; Female ; Hospital Costs ; Humans ; Male ; Middle Aged ; Operative Time ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/economics ; Percutaneous Coronary Intervention/instrumentation ; Postoperative Complications/etiology ; Risk Factors ; Time Factors ; Treatment Outcome ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Safety and efficacy of the hybrid approach in coronary chronic total occlusion percutaneous coronary intervention: The Hybrid Video Registry.
Autorzy :: Daniels DV; Palo Alto Medical Foundation, Palo Alto, California.
Banerjee S; Sacred Heart Medical Center, Eugene, Oregon.
Alaswad K; Appleton Heart Institute, Appleton, Wisconsin.
Doing AH; University of Colorado Health, Ft. Collins, Colorado.
Dattilo PB; Intermountain Healthcare, Ogden, Utah.
Kalyanasundaram A; Seattle Heart and Vascular Institute, Seattle, Washington.
Spratt JC; Forth Valley Royal Hospital, Edinburgh, Scotland.
Hanratty CG; Belfast Health and Social Trust, Belfast, Ireland.
Strange JW; Bristol Heart Institute, University Hospitals Bristol, Bristol, United Kingdom.
Walsh S; Belfast Health and Social Trust, Belfast, Ireland.
Lombardi WL; St. Joseph Medical Center, Bellingham, Washington.
Aaron Grantham J; Mid America Heart Institute, Kansas City, Missouri.; Pokaż więcej
Źródło :: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2018 Feb 01; Vol. 91 (2), pp. 175-179. Date of Electronic Publication: 2017 Nov 29.
Typ publikacji :: Comparative Study; Journal Article; Multicenter Study
MeSH Terms :: Video Recording*
Coronary Occlusion/*surgery
Percutaneous Coronary Intervention/*methods
Coronary Angiography ; Coronary Occlusion/diagnostic imaging ; Coronary Occlusion/physiopathology ; Humans ; Japan ; Operative Time ; Percutaneous Coronary Intervention/adverse effects ; Postoperative Complications/etiology ; Registries ; Risk Factors ; Time Factors ; Treatment Outcome ; United Kingdom ; United States
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Dyspnea Among Patients With Chronic Total Occlusions Undergoing Percutaneous Coronary Intervention: Prevalence and Predictors of Improvement.
Autorzy :: Qintar M; From the Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO (M.Q., J.A.G., K.L.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, University of Missouri-Kansas City (M.Q., J.A.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, Monash Cardiovascular Research Centre, MonashHeart, Monash Health and Department of Medicine (SCS at Monash), Monash University, Melbourne, Australia (J.S.); the Department of Cardiology, University of Washington, Seattle (W.L.); the Department of Cardiology, Columbia University, New York City, NY (D.K., J.M.). .
Grantham JA; From the Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO (M.Q., J.A.G., K.L.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, University of Missouri-Kansas City (M.Q., J.A.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, Monash Cardiovascular Research Centre, MonashHeart, Monash Health and Department of Medicine (SCS at Monash), Monash University, Melbourne, Australia (J.S.); the Department of Cardiology, University of Washington, Seattle (W.L.); the Department of Cardiology, Columbia University, New York City, NY (D.K., J.M.).
Sapontis J; From the Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO (M.Q., J.A.G., K.L.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, University of Missouri-Kansas City (M.Q., J.A.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, Monash Cardiovascular Research Centre, MonashHeart, Monash Health and Department of Medicine (SCS at Monash), Monash University, Melbourne, Australia (J.S.); the Department of Cardiology, University of Washington, Seattle (W.L.); the Department of Cardiology, Columbia University, New York City, NY (D.K., J.M.).
Gosch KL; From the Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO (M.Q., J.A.G., K.L.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, University of Missouri-Kansas City (M.Q., J.A.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, Monash Cardiovascular Research Centre, MonashHeart, Monash Health and Department of Medicine (SCS at Monash), Monash University, Melbourne, Australia (J.S.); the Department of Cardiology, University of Washington, Seattle (W.L.); the Department of Cardiology, Columbia University, New York City, NY (D.K., J.M.).
Lombardi W; From the Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO (M.Q., J.A.G., K.L.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, University of Missouri-Kansas City (M.Q., J.A.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, Monash Cardiovascular Research Centre, MonashHeart, Monash Health and Department of Medicine (SCS at Monash), Monash University, Melbourne, Australia (J.S.); the Department of Cardiology, University of Washington, Seattle (W.L.); the Department of Cardiology, Columbia University, New York City, NY (D.K., J.M.).
Karmpaliotis D; From the Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO (M.Q., J.A.G., K.L.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, University of Missouri-Kansas City (M.Q., J.A.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, Monash Cardiovascular Research Centre, MonashHeart, Monash Health and Department of Medicine (SCS at Monash), Monash University, Melbourne, Australia (J.S.); the Department of Cardiology, University of Washington, Seattle (W.L.); the Department of Cardiology, Columbia University, New York City, NY (D.K., J.M.).
Moses J; From the Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO (M.Q., J.A.G., K.L.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, University of Missouri-Kansas City (M.Q., J.A.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, Monash Cardiovascular Research Centre, MonashHeart, Monash Health and Department of Medicine (SCS at Monash), Monash University, Melbourne, Australia (J.S.); the Department of Cardiology, University of Washington, Seattle (W.L.); the Department of Cardiology, Columbia University, New York City, NY (D.K., J.M.).
Salisbury AC; From the Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO (M.Q., J.A.G., K.L.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, University of Missouri-Kansas City (M.Q., J.A.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, Monash Cardiovascular Research Centre, MonashHeart, Monash Health and Department of Medicine (SCS at Monash), Monash University, Melbourne, Australia (J.S.); the Department of Cardiology, University of Washington, Seattle (W.L.); the Department of Cardiology, Columbia University, New York City, NY (D.K., J.M.).
Cohen DJ; From the Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO (M.Q., J.A.G., K.L.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, University of Missouri-Kansas City (M.Q., J.A.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, Monash Cardiovascular Research Centre, MonashHeart, Monash Health and Department of Medicine (SCS at Monash), Monash University, Melbourne, Australia (J.S.); the Department of Cardiology, University of Washington, Seattle (W.L.); the Department of Cardiology, Columbia University, New York City, NY (D.K., J.M.).
Spertus JA; From the Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO (M.Q., J.A.G., K.L.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, University of Missouri-Kansas City (M.Q., J.A.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, Monash Cardiovascular Research Centre, MonashHeart, Monash Health and Department of Medicine (SCS at Monash), Monash University, Melbourne, Australia (J.S.); the Department of Cardiology, University of Washington, Seattle (W.L.); the Department of Cardiology, Columbia University, New York City, NY (D.K., J.M.).
Arnold SV; From the Department of Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO (M.Q., J.A.G., K.L.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, University of Missouri-Kansas City (M.Q., J.A.G., A.C.S., D.J.C., J.A.S., S.V.A.); the Department of Cardiology, Monash Cardiovascular Research Centre, MonashHeart, Monash Health and Department of Medicine (SCS at Monash), Monash University, Melbourne, Australia (J.S.); the Department of Cardiology, University of Washington, Seattle (W.L.); the Department of Cardiology, Columbia University, New York City, NY (D.K., J.M.).; Pokaż więcej
Źródło :: Circulation. Cardiovascular quality and outcomes [Circ Cardiovasc Qual Outcomes] 2017 Dec; Vol. 10 (12).
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: Percutaneous Coronary Intervention*/adverse effects
Coronary Occlusion/*therapy
Dyspnea/*epidemiology
Lung/*physiopathology
Aged ; Chronic Disease ; Comorbidity ; Coronary Occlusion/diagnostic imaging ; Coronary Occlusion/epidemiology ; Dyspnea/diagnosis ; Dyspnea/physiopathology ; Female ; Humans ; Male ; Middle Aged ; Prevalence ; Prospective Studies ; Quality of Life ; Recovery of Function ; Registries ; Risk Factors ; Sex Factors ; Time Factors ; Treatment Outcome ; United States/epidemiology
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Grantham J"" wg kryterium: Autor

Aktywne filtry:

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język